학술논문

Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study
Document Type
Article
Source
In: British Journal of Haematology. (British Journal of Haematology, June 2023, 201(6):1116-1124)
Subject
Language
English
ISSN
13652141
00071048